How many of you forgot about this stock?
If you invested $10,000 into $Moderna(MRNA.US) at the start of 2026, you'd have approximately $17,000 todayWhy the sudden move for a once dead company:• Fidelity added significantly to their position in Q4 2025• Goldman Sachs raised their price target• BNP Paribas added to their position substantially in Q4 2025• Settled a multi-year mRNA patent dispute• FDA granted expedited review for its flu vaccine, with a decision expected in August 2026Once upon a time, everyone called this stock a "COVID one-hit wonder." Moderna is now one of the best performing stocks in the S&P 500, but it's still down from its ATH of $450/share
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments